Glioblastoma multiforme (GBM) is an aggressive malignancy of the central nervous system, and despite extensive research, progress in altering its lethal prognosis has been limited. There is a growing interest in alternative, metabolic treatments of GBM. The Joseph Maroon diet protocol, often involving a ketogenic diet (KD), has emerged as a potential adjunctive metabolic therapy for patients with GBMs. This article delves into the specifics of the Joseph Maroon diet protocol, exploring its scientific basis, practical implementation, and potential benefits.
Metabolic Therapy and Glioblastoma Multiforme
GBM cells utilize aerobic fermentation of glucose in the cytosol for energy supply instead of mitochondrial oxidative phosphorylation (the “Warburg effect”). The Warburg effect refers to the observation that cancer cells, including those in GBM, primarily rely on glycolysis for energy production, even in the presence of oxygen. This is less efficient than oxidative phosphorylation, requiring cancer cells to consume significantly more glucose.
The "Warburg Effect" and Cancer Glycolysis
In 1931, German scientist Otto Warburg won the Nobel Prize for his significant work in cellular respiration, specifically for “his discovery of the nature and mode of action of the respiratory enzyme". He further demonstrated that malignant cells could survive and proliferate even in hypoxic environments and proposed that all cancers arise from irreversible damage to mitochondria and cellular respiration. Cancer is, Warburg proposed, a metabolic disease.
Glycolysis, the breakdown of glucose into 2 pyruvate, 2 H+, 2 net Adenosine Triphosphate (ATP), two NADH and lactic acid, occurs in nearly all living organisms. This metabolic breakdown of glucose occurs in the cytosol of eukaryotes, where under aerobic conditions, pyruvate is oxidized to produce 36 ATP through the citric acid cycle (CAC) and oxidative phosphorylation (OxPhos). Under anaerobic conditions, pyruvate is reduced to lactate. This process is known as Fermentation. Oxygen inhibits fermentation in healthy cells and in doing so regulates glycolysis. This is known as the ‘Pasteur effect’. In many invasive cancer cells, however, aerobic fermentation is observed. This metabolic shift is known as the “Warburg Effect”. Glucose is transported into the cell where it undergoes glycolysis, the metabolism of glucose to 2 pyruvate, 2 H+, 2 NADH, 2 H2O and 2 net ATP. In healthy cells, the pyruvate subsequently enters the mitochondria where it is converted to Acetyl-CoA, which enters the citric acid cycle (CAC) producing the proton donors for the electron transport chain (ETC) that produces approximately 36 ATP via ATP Synthase. Under anaerobic conditions, pyruvate is fermented to lactate. Much of the pyruvate that is produced in tumor cells through aerobic glycolysis is fermented to lactate rather than oxidized in the mitochondria. It is aerobic fermentation that distinguishes the tumor cell from the normal cell. Tumor cells undergoing aerobic fermentation produce ATP in the cytosol and consume significantly more glucose than healthy cells, but much less efficiently. Aerobic fermentation produces a net 2 ATP compared with the approximately net 36 ATP produced from the CAC and OxPhos. Glycolytic rates 200 times higher than normal cells have been observed. This aberrant bioenergetics and dependency on glucose has become a hallmark of cancer. Increased rates of glycolysis and aerobic fermentation have been observed in many cancer cell lines evidenced by increased expression of glycolytic enzymes, glucose transporters, lactate production, and glucose consumption. Prolonged dependence on glycolysis and fermentation (nonoxidative energy metabolism) has also been shown to induce genomic instability, which could further increase genomic mutations. This dependency of cancer cells, especially those of GBM tumors, on glucose for energy may provide a window for therapeutic management of cancer.
Ketogenic Diet as Adjunctive Therapy
The calorie restricted ketogenic diet (CR-KD) works by restricting GBM cells of glucose, their main energy substrate. The effectiveness of the CR-KD is based on the “Warburg Effect” of cancer metabolism and the microenvironment of GBM tumors. In states of prolonged glucose deprivation, such as fasting or starvation, normal brain cells metabolize ketone bodies derived from fatty acids for energy instead of glucose. Tumor cells are poorly able to do so. They depend on glucose and glycolysis for survival. This makes tumor cells vulnerable to therapies of glucose restriction. Glucose reduction and ketone exposure reduce proliferation and growth rate of human GBM cells and of rodent astrocytoma lines. The effect occurs independently with both glucose reduction and with ketone body exposure, with a synergistic effect between the two. Glucose deprivation results in apoptotic death in human GBM cells but not in normal cells. Similarly, ketone bodies inhibit the viability of cultured human GBM cells, but not of normal cells. Reduction in circulating glucose and increase in ketone levels through ketogenic diet (KD) with caloric restriction have pro-apoptotic, anti-angiogenic, and anti-inflammatory effects, reduce expression of mTOR effector in mice with experimental malignant gliomas, reduce rodent tumor growth and tumor size, and increase survival of animals.
Read also: The Hoxsey Diet
Components of the Joseph Maroon Diet Protocol
While specific protocols may vary, key components of the Joseph Maroon diet often include:
- Ketogenic Diet (KD):
- A low-carbohydrate, high-fat diet designed to shift the body's primary fuel source from glucose to ketone bodies.
- The diet reduces the glucose needed to drive aerobic fermentation (Warburg effect) while also elevating ketone bodies, which cannot be effectively metabolized for energy in tumor cells due to defects in mitochondrial OxPhos.
- Calorie Restriction:
- Reducing overall calorie intake to further deprive cancer cells of glucose.
- Calorie restriction and restricted KD are also anti-angiogenic, anti-inflammatory, anti-invasive, and can kill tumor cells directly through pro-apoptotic mechanisms.
- Supplementation:
- Vitamins, minerals, and other nutrients to support overall health and address potential deficiencies.
Specific Ketogenic Diet Parameters
In a study, KD consisted of 4:1 [fat]:[protein + carbohydrate] ratio by weight, with 10 g CH/day, and with 1600 kcal restriction. The 4:1 KD was chosen because the animal KD study with the greatest treatment effect to date used 4:1 KD. Patients who did not tolerate the 4:1 ratio could choose 3:1 ratio with 20 g CH/day. The diet was supplemented with vitamins, calcium, and phosphorus supplements to meet the requirements of US Dietary Reference Intakes (DRI) standard. The program consisted of 5 meals/day (breakfast, morning snack, lunch, afternoon snack, dinner), different for each day of a 2-week cycle, with repeating cycles. All meals were prepared using designed recipes. All participants received the same meal plan but with recipe adaptation to allow personal or religious dietary restrictions (vegetarian, n = 1, no pork, n = 1) with the same caloric and macronutrient composition. Meals were prepared uniformly by one catering facility and were delivered frozen once a week. Participants were counseled not to eat any other food or and drink only 0 calorie beverages. One patient administered the diet on his own after the first 2 months, using the same KD parameters.
Practical Implementation
Implementing the Joseph Maroon diet protocol requires careful planning and monitoring.
Considerations
- Medical Supervision:
- It's crucial to work with a qualified healthcare professional experienced in ketogenic diets and cancer treatment.
- Nutritional Guidance:
- A registered dietitian can help design a personalized meal plan that meets individual needs and preferences while adhering to the ketogenic and calorie restriction guidelines.
- Monitoring:
- Regularly monitor blood glucose and ketone levels to ensure the diet is achieving the desired metabolic state.
- Monitor for any adverse effects and adjust the diet as needed.
Potential Benefits
- Reduced Glucose Availability:
- By limiting carbohydrate intake, the diet reduces the amount of glucose available to fuel cancer cell growth.
- Ketone Body Production:
- Increased ketone body production provides an alternative energy source for normal brain cells while being less efficiently utilized by cancer cells.
- Anti-angiogenic and Anti-inflammatory Effects:
- Ketogenic diets have been shown to have anti-angiogenic and anti-inflammatory properties, which may further inhibit tumor growth and spread.
Potential Challenges and Mitigation Strategies
- Dietary Adherence:
- The restrictive nature of the ketogenic diet can make it challenging to adhere to long-term.
- Mitigation: Provide education, support, and personalized meal plans to improve adherence.
- Nutrient Deficiencies:
- Restricting certain food groups can lead to nutrient deficiencies.
- Mitigation: Supplement with vitamins and minerals as needed.
- Adverse Effects:
- Some individuals may experience adverse effects such as fatigue, constipation, or electrolyte imbalances.
- Mitigation: Monitor for adverse effects and adjust the diet or supplement regimen as needed.
Case Studies and Research
Case Report
- A 32-year-old man with IDH1-mutant GBM refused standard of care and opted for a self-administered ketogenic diet.
- The tumor continued to grow slowly until 2017, when the patient underwent surgical debulking.
- Following surgery, the patient continued with the ketogenic diet and remained alive with a good quality of life.
- This case suggests a potential therapeutic synergy between KMT and the IDH1 mutation.
Pilot Study
Read also: Walnut Keto Guide
- A pilot study evaluated the feasibility, safety, tolerability, and efficacy of GBM treatment using a total meal replacement (TMR) program with a 4:1 KD.
- The diet was well-tolerated, and some patients experienced symptom reversal and tumor shrinkage.
- The study concluded that treatment of GBM patients with a 4:1 KD using a total meal replacement program was feasible and well-tolerated.
Case Series
- This case series details three women, 40, 54, and 45 years old.
Additional Evidence
- Evidence also shows that therapeutic ketosis can act synergistically with several drugs and procedures to enhance cancer management thus improving both progression free and overall survival.
The Longevity Factor
In his book, The Longevity Factor: How Resveratrol and Red Wine Activate Genes for a Longer and Healthier Life, Dr. Joseph Maroon offers an inside look at research that has led to the discovery of resveratrol and similar substances with the ability to activate longevity genes. He offers his own diet plan and advice for living a longer, healthier, and more balanced life.
Read also: Weight Loss with Low-FODMAP